CHICAGO (GenomeWeb) – Genome.One, an Australian startup offering clinical whole-genome sequencing services to help diagnose rare genetic conditions, will work with Sanford Health to develop a platform to incorporate patient-generated health data into WGS data, the companies announced yesterday.

The two organizations are aiming to combine data provided by Sanford patients with information in electronic health records and genetic and research knowledge bases. This, according to Sanford Health, offers promise for diagnosis and treatment of rare diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.